Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea803fedb641d0973cb43b9fbea9840f |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
filingDate |
2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ee14459309a18becf1f44122d51456 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79858df341fc97ace6612f1bd7e235a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca55d0d2a3214663971b0e3e80ad520 |
publicationDate |
2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016202691-B2 |
titleOfInvention |
Activin-ActRIIa antagonists and uses for promoting bone growth in cancer patients |
abstract |
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma. |
priorityDate |
2007-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |